Skip to main content

Table 6 Adjusted odds ratios and 95% confidence interval for allergic outcomes

From: Maternal phthalate exposure and asthma, rhinitis and eczema in 552 children aged 5 years; a prospective cohort study

Outcome

MEP OR and 95% CI

ΣMBP

OR and 95% CI

ΣDEHPm

OR and 95% CI

ΣDiNPm

OR and 95% CI

Wheeze within the last 2 years

1.00 (0.90,1.11)

0.86 (0.72,1.04)

0.91 (0.78,1.07)

0.89 (0.78,1.02)

Self-reported asthma

1.02 (0.82,1.27)

0.95 (0.67,1.36)

0.98 (0.72,1.33)

0.99 (0.77,1.28)

Doctor-diagnosed asthma

0.91 (0.73,1.12)

0.80 (0.57,1.13)

0.91 (0.68,1.21)

0.94 (0.73,1.21)

Use of medicine against asthma/cold

0.99 (0.88,1.13)

0.86 (0.70,1.08)

0.87 (0.72,1.04)

0.85 (0.72,1.00)

Self-reported eczema

0.81*(0.68,0.96)

0.90 (0.70,1.15)

1.00 (0.80,1.26)

1.03 (0.87,1.22)

Doctor-diagnosed eczema

0.82 (0.66,1.01)

0.79 (0.55,1.10)

0.94 (0.71,1.25)

1.10 (0.90,1.36)

Medicine against eczema

0.88 (0.70,1.10)

0.84 (0.58,1.23)

1.02 (0.72,1.43)

1.24 (1.00,1.55)

Self-reported rhinitis

0.91 (0.75,1.04)

1.11 (0.84,1.46)

1.21 (0.93,1.58)

1.15 (0.97,1.36)

  1. Abbreviations: OR odds ratio; 95% CI 95% confidence interval; MEP monoethyl phthalate; ΣMBP Monobutyl phthalate (i + n), ΣDiNPm sum of Di-isonyl phthalate metabolites; ΣDEHPm sum of Di-2-ethylhexyl phthalate metabolites
  2. Note: ORs were adjusted for maternal age, maternal education, parity and family history of asthma/allergy. * = p < 0.05